Cancer cells, like stem cells, have the ability to multiply indefinitely; epigenetic factor BPTF may be a shared weakness

The term organoid first gained use in the mid-1960?s to describe cell aggregates observed during dissociation and re-aggregation experiments in classic developmental biology. Today, the term organoid refers to three-dimensional structures containing multiple organotypic cell types, recapitulating some of

Researchers from the Japanese RIKEN Centre have reportedly delivered induced pluripotent stem (iPS) cells from an anonymous donor to a 60 year old male patient. The milestone is understood to represent a world first in the development of stem cell technology, in addition to changing the medical approach to how such treatments may become more widely available than first anticipated. Previous protocols have focused on the delivery of a patient?s own cells using a very different clinical procedure to that which may be envisioned from using a ?democratized? cell bank.

According to council public relations and international affairs, the second national festival and international congress on stem cell and regenerative medicine will be held on 13-15 July 2017 in I.R.Iran international conference center ( Saran conference hall ).

A few weeks ago, we reported on the creation of microengineered particle-based cardiac tissue function by functionalizing PLGA microparticles with cardiac cell-extracted growth factors.

Life expectancy will soon exceed 90 years for the first time, scientists have predicted, overturning all the assumptions about human longevity that prevailed at the beginning of the 20th century

Stem cell therapy has turned out to be a ray of hope for most patients who are trying to find a cure for incurable diseases. Researchers and experts believe India has been at the top in the development of stem cell treatment followed by several other countries like China and Japan. However, due to lack of awareness, most people don't think of stem cell therapy as an option for treating most of the incurable diseases.

Dr. Larry Corey has received a $2.6 million grant from Gilead Sciences Inc. to investigate using CAR T cells ? a type of immunotherapy ? to bring about a cure or long-term remission for HIV.

In the past 14 years, Iran has made great strides in stem cell research. And now that Iran is losing its pariah-state status after sanctions were lifted, there are opportunities for collaborations with non-Iranian scientists...

Researchers have harnessed the CRISPR-Cas9 technology to correct mutations in the blood stem cells of patients with a rare immunodeficiency disorder; the engineered cells successfully engrafted in mice for up to five months.